跳至主要内容
临床试验/NCT04280575
NCT04280575已完成不适用

Symptomatic Trial of Angina Assessment Prior to Revascularization: A Placebo-controlled Experiment on Symptoms in Stable Coronary Artery Disease

Imperial College London2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2020年1月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
2
主要终点
Placebo controlled similarity score during low pressure balloon occlusion of the coronary artery

研究概览

简要总结

The principal objective of this research is to determine whether symptoms, induced by confirmed experimental ischaemia, can help us predict which patients will respond to PCI.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Angina or angina-equivalent symptoms
  • Anatomical evidence of a significant single vessel coronary stenosis on diagnostic coronary angiography indicating ≥ 70% stenosis
  • Referred for percutaneous coronary intervention for treatment of stable angina

排除标准

  • Age younger than 18
  • Age older than 85
  • Recent acute coronary syndrome
  • Multivessel coronary artery disease
  • Previous coronary artery bypass graft surgery
  • Significant left main stem coronary disease
  • Chronic total occlusion in the target vessel
  • Contraindication to percutaneous coronary intervention or drug-eluting stent implantation
  • Contraindication to antiplatelet therapy
  • Contraindication to adenosine infusion
  • Severe valvular disease
  • Severe LV systolic impairment
  • Severe respiratory disease
  • Life expectancy less than 2 years, pregnancy, unable to consent

结局指标

主要结局

Placebo controlled similarity score during low pressure balloon occlusion of the coronary artery

时间窗: 30 Days

Similarity Score (1-10) (Higher Score = Better Outcome)

次要结局

  • Change in angina symptom score(30 Days)
  • Change in treadmill time to chest pain(30 Days)
  • Physical limitation, angina stability, quality of life, angina frequency, freedom from angina as assessed with the Seattle Angina Questionnaire.(30 Days)
  • Quality of Life assessed with the EQ-5D-5L questionnaire(30 Days)
  • Need for anti-anginal medication introduction and uptitration(30 Days)
  • Change in treadmill exercise time(30 Days)
  • Change in dobutamine stress echocardiography score(30 Days)
  • Depression as assessed by the PHQ-9 Score(30 days)
  • Angina severity as assessed by Canadian Cardiovascular Society Class(30 Days)
  • Anxiety as assessed by the GAD-7 Score(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验